Key facts
- SRT Therapeutics’s last known valuation is $69.0M (Aug 2025).
- It has raised $47.4M across 1 recorded rounds; the latest was Early Stage VC ($47.4M) in Apr 2025.
- SRT Therapeutics has filed 1 Form D with the SEC, most recently Aug 2025 ($47.4M sold to 55 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for SRT Therapeutics
Create free account
No card required
Funding rounds
1 roundsAbout SRT Therapeutics
The company is currently operating in Stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- San Diego, CA, United States
- Founded
- 2024
- Employees
- 15
- Website
- srt-tx.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
SRT Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in SRT Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on SRT Therapeutics in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.